David Greenwald

Relay Technology Management is a life sciences business intelligence software provider founded in 2008 with one core belief that enabling data-driven decision-making via objective, standard asset valuation and trend analytics will lead to increased efficiency in drug development. Data-driven decision-making in turn will lead to cures for patients around the world becoming available faster. The Relay Innovation Engine software platform powers the Business Development Live software-as-a-service and their strategy consulting practice, which supports business development and corporate strategy professionals by aggregating scientific, business and medical data in an actionable context. Relay works with life science companies to increase the efficiency of drug development by offering a transparent, objective and scalable approach to business intelligence and analytics. Relay was founded by David Greenwald, Ph.D. and Brigham Hyde, Ph.D.

Deerfield Management Co. LP (Private Equity) (Deerfield) is a private equity subsidiary of Deerfield Management Co. LP founded in 1994. The firm is headquartered in the New York.

CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA.

Jaguar Gene Therapy LLC is a clinical stage biotechnology company based in Lake Forest, IL. Jaguar Gene Therapy LLC is dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company has a proven team of experts who have experience in bringing novel gene therapy treatments to patients and their families. Jaguar is rapidly advancing an initial pipeline of three programs, including targeting severe neurodevelopmental disorders, type 1 galactosemia, and type 1 diabetes. The company partner with Advanced Medicine Partners for manufacturing their therapeutics. Key investors include Deerfield Management Company, Arch Venture Partners, and Eli Lilly and Company. The company was founded by Daniel Gallo, and Joseph Nolan has been the CEO since 2020.